67 Spam-Free Article(s) Found
Sort:
Like
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Monday’s Close
LLY Eli Lilly and Company $105.71 $113.53B N/A
Article Searches
3 Drugmakers Still Worth Betting on Amid Coronavirus Woes http://www.zacks.com/stock/news/849056/3-drugmakers-still-worth-betting-on-amid-coronavirus-woes?cid=CS-ZC-FT-analyst_blog|investment_ideas-849056 Apr 01, 2020 - Here we provide three stocks from the drug and biotech sector which can offer protection to an investor's portfolio amid stock market turmoil due to coronavirus crisis.
3 Stocks Immune to the Coronavirus Downturn to Buy Right Now http://www.zacks.com/stock/news/857564/3-stocks-immune-to-the-coronavirus-downturn-to-buy-right-now?cid=CS-ZC-FT-zacks_friday_finish_line-857564 Apr 06, 2020 - Today's episode of Full Court Finance here at Zacks quickly dives into why Wall Street seems optimistic on Monday. Despite the positivity, investors should still be on the hunt for stocks that appear immune to the broader coronavirus fallout...
5 Low-Risk Stocks to Buy for Epic Price Swings Since 1929 http://www.zacks.com/stock/news/860620/5-low-risk-stocks-to-buy-for-epic-price-swings-since-1929?cid=CS-ZC-FT-analyst_blog|investment_ideas-860620 Apr 08, 2020 - The S&P 500's average daily percentage price change over the past five weeks has been plus or minus 4.8%. This explains why the Cboe Volatility Index remains elevated at around the 40s.
5 Stocks With Recent Price Strength Amid Coronavirus Logjam http://www.zacks.com/stock/news/862418/5-stocks-with-recent-price-strength-amid-coronavirus-logjam?cid=CS-ZC-FT-analyst_blog|rw-862418 Apr 09, 2020 - Investors target stocks that are witnessing a bullish run. Actually, stocks seeing price strength have a high chance of carrying the momentum forward.
Zacks.com featured highlights include: Electromed, NovaGold Resources, FTI Consulting, Eli Lilly and Masimo http://www.zacks.com/stock/news/868599/zackscom-featured-highlights-include-electromed-novagold-resources-fti-consulting-eli-lilly-and-masimo?cid=CS-ZC-FT-press_releases-868599 Apr 13, 2020 - Zacks.com featured highlights include: Electromed, NovaGold Resources, FTI Consulting, Eli Lilly and Masimo
SNY vs. LLY: Which Stock Is the Better Value Option? http://www.zacks.com/stock/news/870517/sny-vs-lly-which-stock-is-the-better-value-option?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_3-870517 Apr 14, 2020 - SNY vs. LLY: Which Stock Is the Better Value Option?
CytoDyn's Leronlimab Progressing Well in Coronavirus Program http://www.zacks.com/stock/news/874193/cytodyns-leronlimab-progressing-well-in-coronavirus-program?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-874193 Apr 16, 2020 - CytoDyn (CYDY) treats first patient in a phase IIb/III study evaluating leronlimab in severe and critically ill COVID-19 patients. A phase II study on leronlimab shows encouraging results in mild-to-moderate COVID-19 patients.
Ericsson (ERIC) to Report Q1 Earnings: What's in the Offing? http://www.zacks.com/stock/news/880321/ericsson-eric-to-report-q1-earnings-whats-in-the-offing?cid=CS-ZC-FT-analyst_blog|earnings_preview-880321 Apr 20, 2020 - Ericsson's (ERIC) first-quarter performance is likely to have benefited from momentum in business led by its strategy to increase investments for technology leadership, including 5G.
Q1 Earnings Scorecard and Analyst Reports for Exxon, Oracle & Eli Lilly http://www.zacks.com/research-daily/882127/q1-earnings-scorecard-and-analyst-reports-for-exxon-oracle-eli-lilly?cid=CS-ZC-FT-research_daily-882127 Apr 21, 2020 - Q1 Earnings Scorecard and Analyst Reports for Exxon, Oracle & Eli Lilly
Can Lilly (LLY) Deliver a Beat in Coronavirus-Hit Q1 Earnings? http://www.zacks.com/stock/news/882090/can-lilly-lly-deliver-a-beat-in-coronavirus-hit-q1-earnings?cid=CS-ZC-FT-analyst_blog|earnings_preview-882090 Apr 21, 2020 - Investor focus is likely to be on the impact of the coronavirus outbreak on Lilly's (LLY) performance when it reports first-quarter results.

Pages: 1234567

<Page 2>